Quality of service provision for anticoagulation in atrial fibrillation

[...]clinicians are concerned that studies select patients too carefuly, thus maximising both the effects of the clinical risk and responsiveness to the intervention. 2 This bias may be addressed by selecting and monitoring "real life" patients as carefully as is done in the trials. 1 But...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 1996-01, Vol.312 (7022), p.51-53
Main Authors: Edwards, Adrian, Pill, Roisin, Lip, Gregory Y. H., Scott, Michael E., Wallace, William F. M., Marshall, Tom, Davis, R. C., Eskola, K., Virjo, I., Isokoski, M., Aittobiemi, Pirjo, Kurunmǎki, H., Latva-Nevala, A., Paloneva, M., Wallin, A.-M., Viitaniemi, M., Ylinen, S., Öhman, S.
Format: Article
Language:English
Subjects:
Anticoagulants
Atrial fibrillation
Bleeding
Cardiology
Electric countershock
General practice
Hospital admissions
Letters
Physicians
Strokes
Thromboembolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]clinicians are concerned that studies select patients too carefuly, thus maximising both the effects of the clinical risk and responsiveness to the intervention. 2 This bias may be addressed by selecting and monitoring "real life" patients as carefully as is done in the trials. 1 But a second barrier to implementation of the results can be envisaged: if one uses the criteria for entry to the anticoagulation trials as the basis for deciding who should receive treatment then 60-97% of patients would be ineligible. 1 If, for example, only 1 in 10 qualifies according to these criteria then a practitioner may find the time burdens of assessment excessive in relation to the clinical activity implemented.
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.312.7022.51